Published in Clin Infect Dis on May 15, 2008
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. N Engl J Med (2015) 6.04
Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia. Clin Infect Dis (2016) 3.58
Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev (2015) 1.94
Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques. PLoS One (2013) 1.84
Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010. Emerg Infect Dis (2011) 1.80
Use of a rapid test of pneumococcal colonization density to diagnose pneumococcal pneumonia. Clin Infect Dis (2011) 1.70
Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations. Lung India (2012) 1.40
Lower respiratory tract virus findings in mechanically ventilated patients with severe community-acquired pneumonia. Clin Infect Dis (2014) 1.36
Systematic review and meta-analysis of a urine-based pneumococcal antigen test for diagnosis of community-acquired pneumonia caused by Streptococcus pneumoniae. J Clin Microbiol (2013) 1.25
Role of the neutrophil-lymphocyte count ratio in the differential diagnosis between pulmonary tuberculosis and bacterial community-acquired pneumonia. Ann Lab Med (2013) 1.14
The impact of bacterial and viral co-infection in severe influenza. Influenza Other Respir Viruses (2012) 1.05
Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway. BMC Infect Dis (2015) 0.95
What is the role of respiratory viruses in community-acquired pneumonia?: What is the best therapy for influenza and other viral causes of community-acquired pneumonia? Infect Dis Clin North Am (2012) 0.93
Effect of antimicrobial use on pneumococcal diagnostic tests in elderly patients with community-acquired pneumonia. Eur J Clin Microbiol Infect Dis (2014) 0.88
Aetiology of community-acquired pneumonia among adults in an H1N1 pandemic year: the role of respiratory viruses. Eur J Clin Microbiol Infect Dis (2012) 0.88
Clinical features of endemic community-acquired psittacosis. New Microbes New Infect (2014) 0.87
Evaluation of yield of currently available diagnostics by sample type to optimize detection of respiratory pathogens in patients with a community-acquired pneumonia. Influenza Other Respir Viruses (2013) 0.84
Acute lower respiratory infections in ≥ 5 year -old hospitalized patients in Cambodia, a low-income tropical country: clinical characteristics and pathogenic etiology. BMC Infect Dis (2013) 0.83
Etiological analysis and predictive diagnostic model building of community-acquired pneumonia in adult outpatients in Beijing, China. BMC Infect Dis (2013) 0.82
Severity of influenza A 2009 (H1N1) pneumonia is underestimated by routine prediction rules. Results from a prospective, population-based study. PLoS One (2012) 0.82
Bacterial etiologies of five core syndromes: laboratory-based syndromic surveillance conducted in Guangxi, China. PLoS One (2014) 0.79
What about viral community acquired pneumonias? BMJ (2008) 0.79
Comparison of immunoglobulin G subclass concentrations in severe community-acquired pneumonia and severe pandemic 2009 influenza A (H1N1) infection. Clin Vaccine Immunol (2012) 0.78
Respiratory virus is a real pathogen in immunocompetent community-acquired pneumonia: comparing to influenza like illness and volunteer controls. BMC Pulm Med (2014) 0.77
Mortality Risk and Etiologic Spectrum of Community-acquired Pneumonia in Hospitalized Adult Patients. Maedica (Buchar) (2010) 0.77
Mortality in healthcare-associated pneumonia in a low resistance setting: a prospective observational study. Infect Dis (Lond) (2015) 0.76
Copeptin for risk stratification in non-traumatic headache in the emergency setting: a prospective multicenter observational cohort study. J Headache Pain (2017) 0.75
The Diagnostic Utility of Induced Sputum Microscopy and Culture in Childhood Pneumonia. Clin Infect Dis (2017) 0.75
Utility of oropharyngeal real-time PCR for S. pneumoniae and H. influenzae for diagnosis of pneumonia in adults. Eur J Clin Microbiol Infect Dis (2016) 0.75
Treatment of community-acquired pneumonia Down Under versus the United States: is it really that different? Clin Infect Dis (2008) 0.75
Prevalence of Atypical Pathogens in Patients With Cough and Community-Acquired Pneumonia: A Meta-Analysis. Ann Fam Med (2016) 0.75
Burden of pneumococcal disease in adults aged 65 years and older: an Australian perspective. Pneumonia (Nathan) (2016) 0.75
Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis (2003) 13.83
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. N Engl J Med (2015) 6.04
Peripheral intravenous catheter-associated Staphylococcus aureus bacteraemia: more than 5 years of prospective data from two tertiary health services. Med J Aust (2013) 4.93
Routine versus clinically indicated replacement of peripheral intravenous catheters: a randomised controlled equivalence trial. Lancet (2012) 4.51
Clinical practice. Community-acquired pneumonia. N Engl J Med (2014) 4.14
Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. Clin Infect Dis (2004) 4.06
Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations. J Infect Dis (2011) 3.98
Therapeutic efficacy and safety of chaperonin 10 in patients with rheumatoid arthritis: a double-blind randomised trial. Lancet (2006) 3.86
Sleepiness, sleep-disordered breathing, and accident risk factors in commercial vehicle drivers. Am J Respir Crit Care Med (2004) 3.14
Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi Metallo-β-lactamase. Clin Infect Dis (2011) 3.06
Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease). J Am Coll Cardiol (2012) 2.60
SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis (2008) 2.56
Incidence and characteristics of endemic Norwalk-like virus-associated gastroenteritis. J Med Virol (2003) 2.49
Severity of pneumococcal pneumonia associated with genomic bacterial load. Chest (2009) 2.46
CICADA: Cough in Children and Adults: Diagnosis and Assessment. Australian cough guidelines summary statement. Med J Aust (2010) 2.34
Efficacy of an alcohol/chlorhexidine hand hygiene program in a hospital with high rates of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection. Med J Aust (2005) 2.29
Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand. Med J Aust (2009) 2.16
Further evidence that the IS481 target is suitable for real-time PCR detection of Bordetella pertussis. Pathology (2013) 2.13
Lung T-cell responses to nontypeable Haemophilus influenzae in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol (2012) 2.10
Association between surfactant protein B + 1580 polymorphism and the risk of respiratory failure in adults with community-acquired pneumonia. Crit Care Med (2004) 2.07
Genetic diversity among community methicillin-resistant Staphylococcus aureus strains causing outpatient infections in Australia. J Clin Microbiol (2004) 2.03
What's hanging around your neck? Pathogenic bacteria on identity badges and lanyards. Med J Aust (2008) 2.03
Tuberculin-purified protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis. Clin Diagn Lab Immunol (1999) 1.97
Malaria acquired in Bali. Med J Aust (1995) 1.93
Probiotic treatment of vancomycin-resistant enterococci: a randomised controlled trial. Med J Aust (2007) 1.88
Direct detection of vanB2 using the Roche LightCycler vanA/B detection assay to indicate vancomycin-resistant enterococcal carriage--sensitive but not specific. J Antimicrob Chemother (2007) 1.88
Methicillin-resistant Staphylococcus aureus genotyping using a small set of polymorphisms. J Med Microbiol (2006) 1.87
Antibiotic resistance is an emerging threat to public health: an urgent call to action at the Antimicrobial Resistance Summit 2011. Med J Aust (2011) 1.86
Adaptive immunity to nontypeable Haemophilus influenzae. Am J Respir Crit Care Med (2002) 1.83
Comparison of three PCR primer sets for identification of vanB gene carriage in feces and correlation with carriage of vancomycin-resistant enterococci: interference by vanB-containing anaerobic bacilli. Antimicrob Agents Chemother (2005) 1.81
Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii. Clin Infect Dis (2013) 1.76
Detection of novel influenza A(H1N1) virus by real-time RT-PCR. J Clin Virol (2009) 1.75
Methicillin-resistant Staphylococcus aureus in the Australian community: an evolving epidemic. Med J Aust (2006) 1.73
Emergence of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infection in Queensland, Australia. Int J Infect Dis (2003) 1.68
Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand. Med J Aust (2010) 1.66
Ceftriaxone and cefotaxime use in Victorian hospitals. Med J Aust (2002) 1.63
Prevalence of antimicrobial-resistant organisms in residential aged care facilities. Med J Aust (2011) 1.62
A fatal case of necrotising pneumonia due to community-associated methicillin-resistant Staphylococcus aureus. Med J Aust (2007) 1.61
Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: a prospective open-label randomized controlled trial in nonresponders to primary vaccination. Am J Kidney Dis (2009) 1.61
Catheter-related bloodstream infections in intensive care units: a systematic review with meta-analysis. J Adv Nurs (2008) 1.61
Enterococcal vanB resistance locus in anaerobic bacteria in human faeces. Lancet (2001) 1.60
Is fosfomycin a potential treatment alternative for multidrug-resistant gram-negative prostatitis? Clin Infect Dis (2013) 1.60
Molecular characterization of vanB elements in naturally occurring gut anaerobes. Antimicrob Agents Chemother (2005) 1.58
Rapid detection of vanA and vanB genes directly from clinical specimens and enrichment broths by real-time multiplex PCR assay. J Clin Microbiol (2003) 1.53
Microbiologic follow-up study in adult bronchiectasis. Respir Med (2007) 1.52
Duration of short-course androgen suppression therapy and the risk of death as a result of prostate cancer. J Clin Oncol (2011) 1.51
Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA. Antimicrob Agents Chemother (2009) 1.50
Prevention of needlestick injuries: the need for strategic marketing to address health care worker misperceptions. Am J Infect Control (2007) 1.46
Duration of in vivo antimicrobial activity of antibiotic-impregnated cerebrospinal fluid catheters. Neurosurgery (2006) 1.45
Can whole genome analysis refine the taxonomy of the genus Rhodococcus? FEMS Microbiol Rev (2004) 1.44
Overcrowding and understaffing in modern health-care systems: key determinants in meticillin-resistant Staphylococcus aureus transmission. Lancet Infect Dis (2008) 1.44
Effect of healthcare-acquired infection on length of hospital stay and cost. Infect Control Hosp Epidemiol (2007) 1.43
A comparison of two dosing regimens of zidovudine in Thai adults with early symptomatic HIV infection. Conducting clinical HIV trials in South-East Asia. Aust N Z J Med (2000) 1.42
Evolution and diversity of community-associated methicillin-resistant Staphylococcus aureus in a geographical region. BMC Microbiol (2011) 1.41
Co-existing conditions for deaths from infectious and parasitic diseases in Australia. Int J Infect Dis (2004) 1.39
Abnormal vocal cord movement treated with botulinum toxin in patients with asthma resistant to optimised management. Respirology (2014) 1.38
HIV in the suburbs. Med J Aust (1993) 1.38
One-Minute Walk and modified Timed Up and Go tests in children with cerebral palsy: performance and minimum clinically important differences. Dev Med Child Neurol (2014) 1.38
Staphylococcus aureus genotyping using novel real-time PCR formats. J Clin Microbiol (2006) 1.38
Antibiotic prophylaxis for cardiac surgery - are we getting it right? Med J Aust (2010) 1.38
Vancomycin AUC/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremia. Antimicrob Agents Chemother (2013) 1.38
A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses. J Antimicrob Chemother (1996) 1.36
Staphylococcus aureus bacteremia, Australia. Emerg Infect Dis (2005) 1.35
In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J Appl Bacteriol (1995) 1.34
A quantitative LightCycler PCR to detect Streptococcus pneumoniae in blood and CSF. Diagn Microbiol Infect Dis (2003) 1.34
Effect of pressure ulcers on length of hospital stay. Infect Control Hosp Epidemiol (2005) 1.33
Methicillin-resistant Staphylococcus aureus clones, Western Australia. Emerg Infect Dis (2006) 1.33
Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G(2) subclass deficiency. Clin Infect Dis (2010) 1.32
Community-acquired MRSA bacteraemia: four additional cases including one associated with severe pneumonia. Med J Aust (2003) 1.30
High rates of fecal carriage of nonenterococcal vanB in both children and adults. Antimicrob Agents Chemother (2008) 1.29
Nematode symbiont for Photorhabdus asymbiotica. Emerg Infect Dis (2006) 1.26
The impact of estrogen and progesterone on asthma. Ann Allergy Asthma Immunol (2003) 1.26
A quantitative assessment of the efficacy of surgical and N95 masks to filter influenza virus in patients with acute influenza infection. Clin Infect Dis (2009) 1.25
Random amplified polymorphic DNA and plasmid analyses used in investigation of an outbreak of multiresistant Klebsiella pneumoniae. J Clin Microbiol (1995) 1.25
Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a single institution over a 10-year period. J Clin Microbiol (2010) 1.25
Australasian Society for Infectious Diseases guidelines for the diagnosis and treatment of Clostridium difficile infection. Med J Aust (2011) 1.22
"Down the drain": carbapenem-resistant bacteria in intensive care unit patients and handwashing sinks. Med J Aust (2013) 1.21
In vitro activity of sparfloxacin (AT-4140, CI-978, PD 131501), a new quinolone antimicrobial agent. Diagn Microbiol Infect Dis (1991) 1.19
Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion. Chest (2012) 1.18
Differentiation of clonal complex 59 community-associated methicillin-resistant Staphylococcus aureus in Western Australia. Antimicrob Agents Chemother (2010) 1.18
Psittacosis--a review of 135 cases. Med J Aust (1988) 1.17
The dominant Australian community-acquired methicillin-resistant Staphylococcus aureus clone ST93-IV [2B] is highly virulent and genetically distinct. PLoS One (2011) 1.16
Low-level vancomycin resistance in Staphylococcus aureus--an Australian perspective. Eur J Clin Microbiol Infect Dis (2005) 1.16
Identification of type 3 fimbriae in uropathogenic Escherichia coli reveals a role in biofilm formation. J Bacteriol (2007) 1.16
bla(SHV) Genes in Klebsiella pneumoniae: different allele distributions are associated with different promoters within individual isolates. Antimicrob Agents Chemother (2005) 1.15
Virulence properties of asymptomatic bacteriuria Escherichia coli. Int J Med Microbiol (2008) 1.15
Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin. Med J Aust (2001) 1.15
Severe photosensitivity causing multifocal squamous cell carcinomas secondary to prolonged voriconazole therapy. Clin Infect Dis (2007) 1.15